See more : Spacefy Inc. (SPFYF) Income Statement Analysis – Financial Results
Complete financial analysis of Rite Aid Corporation (RAD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rite Aid Corporation, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- China Brilliant Global Limited (8026.HK) Income Statement Analysis – Financial Results
- Bureau Veritas SA (BVI.PA) Income Statement Analysis – Financial Results
- Flying Nickel Mining Corp. (FLYNF) Income Statement Analysis – Financial Results
- Econach Holdings Co.,Ltd. (3521.T) Income Statement Analysis – Financial Results
- Phoenix International Limited (PHOENXINTL.BO) Income Statement Analysis – Financial Results
Rite Aid Corporation (RAD)
About Rite Aid Corporation
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.09B | 24.57B | 24.04B | 21.93B | 21.64B | 21.53B | 22.93B | 30.74B | 26.53B | 25.53B | 25.39B | 26.12B | 25.21B | 25.67B | 26.29B | 24.33B | 17.51B | 17.27B | 16.82B | 16.60B | 15.80B | 15.17B | 14.52B | 14.68B | 12.73B | 11.38B | 6.97B | 5.45B | 4.53B | 4.06B | 4.09B | 3.75B | 3.45B | 3.17B | 2.87B | 2.49B | 1.76B | 1.56B |
| Cost of Revenue | 19.29B | 19.46B | 19.34B | 17.20B | 16.96B | 16.75B | 17.86B | 22.91B | 18.95B | 18.20B | 18.07B | 19.33B | 18.52B | 18.85B | 19.25B | 17.69B | 12.79B | 12.57B | 12.61B | 12.57B | 12.11B | 11.74B | 10.77B | 10.97B | 9.14B | 8.02B | 4.94B | 3.90B | 3.23B | 2.87B | 2.89B | 2.63B | 2.39B | 2.20B | 1.98B | 1.73B | 1.21B | 1.08B |
| Gross Profit | 4.80B | 5.11B | 4.70B | 4.73B | 4.68B | 4.78B | 5.06B | 7.83B | 7.58B | 7.32B | 7.32B | 6.79B | 6.69B | 6.82B | 7.04B | 6.64B | 4.72B | 4.70B | 4.21B | 4.03B | 3.69B | 3.43B | 3.75B | 3.71B | 3.59B | 3.36B | 2.03B | 1.55B | 1.30B | 1.18B | 1.19B | 1.12B | 1.05B | 973.00M | 885.00M | 756.30M | 546.80M | 485.50M |
| Gross Profit Ratio | 19.94% | 20.78% | 19.57% | 21.56% | 21.61% | 22.20% | 22.09% | 25.46% | 28.56% | 28.69% | 28.82% | 26.01% | 26.54% | 26.58% | 26.76% | 27.28% | 26.94% | 27.21% | 25.02% | 24.29% | 23.36% | 22.60% | 25.83% | 25.29% | 28.23% | 29.52% | 29.06% | 28.41% | 28.77% | 29.18% | 29.22% | 29.83% | 30.55% | 30.67% | 30.85% | 30.42% | 31.13% | 31.04% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.60B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 3.37B | 3.46B | 3.71B | 2.64B | 2.39B | 1.43B | 1.10B | 932.20M | 1.01B | 847.70M | 781.90M | 732.90M | 700.10M | 613.60M | 506.50M | 346.60M | 304.50M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 483.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 352.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.90B | 5.03B | 4.66B | 4.59B | 4.59B | 4.65B | 4.78B | 7.01B | 6.70B | 6.56B | 6.60B | 6.53B | 6.46B | 6.58B | 6.99B | 6.37B | 4.37B | 4.31B | 3.76B | 3.65B | 3.41B | 4.20B | 4.65B | 4.21B | 2.94B | 2.67B | 1.60B | 1.22B | 1.03B | 1.11B | 946.00M | 875.40M | 826.20M | 784.50M | 690.40M | 567.50M | 390.90M | 341.70M |
| Cost & Expenses | 24.19B | 24.50B | 24.00B | 21.79B | 21.56B | 21.40B | 22.64B | 29.92B | 25.65B | 24.76B | 24.67B | 25.86B | 24.98B | 25.43B | 26.24B | 24.06B | 17.16B | 16.88B | 16.37B | 16.22B | 15.52B | 15.94B | 15.42B | 15.18B | 12.08B | 10.69B | 6.55B | 5.12B | 4.26B | 3.98B | 3.84B | 3.51B | 3.22B | 2.98B | 2.67B | 2.30B | 1.60B | 1.42B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 224.40M | 191.60M | 201.39M | 229.66M | 227.73M | 202.77M | 200.07M | 449.57M | 397.61M | 424.59M | 515.42M | 529.26M | 547.58M | 515.76M | 477.63M | 449.60M | 275.22M | 277.02M | 294.87M | 313.50M | 396.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 276.58M | 295.69M | 327.12M | 328.28M | 357.88M | 386.06M | 407.37M | 509.21M | 416.63M | 403.74M | 414.11M | 440.58M | 505.55M | 534.24M | 586.21M | 472.47M | 270.31M | 249.76M | 246.74M | 264.29M | 285.33M | 349.84M | 384.07M | 501.00M | 302.60M | 274.20M | 168.10M | 118.70M | 98.60M | 95.70M | 98.30M | 93.50M | 93.30M | 84.40M | 76.80M | 61.00M | 44.30M | 37.20M |
| EBITDA | 178.44M | 368.31M | 374.26M | 467.70M | 441.86M | 514.90M | 695.08M | 1.32B | 1.30B | 1.17B | 1.45B | 702.51M | 762.44M | 778.10M | -2.91B | -1.08B | 834.33M | 918.46M | 718.57M | 686.98M | 681.40M | -17.56M | -11.40M | 95.52M | 1.21B | 964.00M | 659.70M | 443.20M | 372.40M | 170.10M | 345.90M | 336.30M | 320.40M | 272.90M | 268.30M | 247.40M | 195.40M | 177.00M |
| EBITDA Ratio | 0.74% | 1.50% | 1.56% | 2.13% | 2.04% | 2.39% | 3.03% | 4.30% | 4.89% | 4.57% | 4.46% | 2.69% | 3.02% | 3.03% | 10.62% | 3.45% | 3.84% | 4.13% | 4.27% | 4.14% | 4.31% | -0.12% | -0.08% | 0.65% | 9.52% | 8.47% | 9.46% | 8.14% | 8.21% | 4.19% | 8.47% | 8.97% | 9.29% | 8.60% | 9.35% | 9.95% | 11.12% | 11.32% |
| Operating Income | -98.15M | 72.62M | 47.14M | 139.42M | 83.98M | 128.84M | 287.71M | 812.91M | 881.09M | 762.57M | 717.51M | 261.92M | 256.90M | 243.86M | 2.21B | 366.78M | 402.48M | 463.10M | 471.83M | 422.69M | 396.07M | -367.40M | -395.47M | -405.47M | 909.00M | 689.80M | 491.60M | 324.50M | 273.80M | 74.40M | 247.60M | 242.80M | 227.10M | 188.50M | 191.50M | 186.40M | 151.10M | 139.80M |
| Operating Income Ratio | -0.41% | 0.30% | 0.20% | 0.64% | 0.39% | 0.60% | 1.25% | 2.64% | 3.32% | 2.99% | 2.83% | 1.00% | 1.02% | 0.95% | 8.39% | 1.51% | 2.30% | 2.68% | 2.81% | 2.55% | 2.51% | -2.42% | -2.72% | -2.76% | 7.14% | 6.06% | 7.05% | 5.96% | 6.04% | 1.83% | 6.06% | 6.48% | 6.59% | 5.94% | 6.68% | 7.50% | 8.60% | 8.94% |
| Total Other Income/Expenses | -658.26M | -614.88M | -20.16M | -221.03M | -673.45M | -172.39M | -239.19M | -534.51M | -454.27M | -512.35M | -710.01M | -261.89M | 9.84M | 26.76M | -2.63B | -544.94M | -388.90M | -419.85M | -168.47M | -403.12M | -167.64M | -405.44M | -887.34M | -710.27M | -709.40M | -159.80M | -164.60M | -68.30M | -42.30M | -28.70M | -33.00M | -40.80M | -52.40M | -54.70M | -40.30M | -32.20M | -18.10M | -11.90M |
| Income Before Tax | -756.40M | -542.26M | -120.23M | -81.61M | -589.48M | -43.55M | 48.52M | 278.40M | 426.82M | 250.22M | 7.51M | -392.26M | -545.58M | -479.92M | -2.58B | -273.50M | 13.58M | 43.25M | 134.01M | 34.52M | -167.64M | -772.84M | -1.28B | -1.12B | 199.60M | 530.00M | 258.90M | 256.20M | 231.50M | 45.70M | 214.60M | 202.00M | 174.70M | 133.80M | 154.30M | 156.60M | 137.80M | 127.90M |
| Income Before Tax Ratio | -3.14% | -2.21% | -0.50% | -0.37% | -2.72% | -0.20% | 0.21% | 0.91% | 1.61% | 0.98% | 0.03% | -1.50% | -2.16% | -1.87% | -9.82% | -1.12% | 0.08% | 0.25% | 0.80% | 0.21% | -1.06% | -5.09% | -8.84% | -7.60% | 1.57% | 4.66% | 3.71% | 4.70% | 5.11% | 1.13% | 5.25% | 5.39% | 5.07% | 4.22% | 5.38% | 6.30% | 7.84% | 8.18% |
| Income Tax Expense | -6.47M | -3.78M | -20.16M | 387.61M | 77.48M | 305.99M | 44.44M | 112.94M | -1.68B | 804.00K | -110.60M | -23.69M | 9.84M | 26.76M | 329.26M | 802.70M | -13.24M | -1.23B | -168.47M | -48.80M | -41.94M | -11.75M | 148.96M | 8.00K | 55.90M | 213.60M | 98.40M | 97.30M | 90.20M | 19.50M | 82.20M | 78.00M | 67.40M | 51.90M | 59.10M | 62.80M | 59.80M | 60.00M |
| Net Income | -749.94M | -538.48M | -100.07M | -469.22M | -422.21M | 943.47M | 4.05M | 165.47M | 2.11B | 249.41M | 118.11M | -368.57M | -555.42M | -506.68M | -2.92B | -1.08B | 26.83M | 1.27B | 302.48M | 83.31M | -112.08M | -827.68M | -1.59B | -1.14B | 143.70M | 316.40M | 115.30M | 158.90M | 141.30M | 9.30M | 132.40M | 124.00M | 107.30M | 102.10M | 95.20M | 140.90M | 78.00M | 62.50M |
| Net Income Ratio | -3.11% | -2.19% | -0.42% | -2.14% | -1.95% | 4.38% | 0.02% | 0.54% | 7.95% | 0.98% | 0.47% | -1.41% | -2.20% | -1.97% | -11.09% | -4.44% | 0.15% | 7.37% | 1.80% | 0.50% | -0.71% | -5.46% | -10.95% | -7.79% | 1.13% | 2.78% | 1.65% | 2.92% | 3.12% | 0.23% | 3.24% | 3.31% | 3.11% | 3.22% | 3.32% | 5.67% | 4.44% | 4.00% |
| EPS | -13.71 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 43.40 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 47.20 | 10.05 | 2.27 | -4.34 | -35.03 | -111.20 | -88.19 | -35.80 | -14.80 | 6.30 | 9.50 | 16.70 | 0.90 | 7.50 | 7.10 | 3.25 | 3.10 | 2.85 | 4.30 | 2.40 | 1.90 |
| EPS Diluted | -13.64 | -9.96 | -1.87 | -8.82 | -7.99 | 17.98 | 0.08 | 3.20 | 41.60 | 4.60 | 2.40 | -8.32 | -12.58 | -11.50 | -69.35 | -29.81 | -0.20 | 37.80 | 8.25 | 2.23 | -4.34 | -35.03 | -95.73 | -88.19 | -35.80 | -14.80 | 6.30 | 9.20 | 16.70 | 0.90 | 7.30 | 7.00 | 3.25 | 3.05 | 2.85 | 4.30 | 2.40 | 1.90 |
| Weighted Avg Shares Out | 54.68M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 52.22M | 51.22M | 48.56M | 46.11M | 44.48M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 26.20M | 26.98M | 20.67M | 25.85M | 23.62M | 14.29M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
| Weighted Avg Shares Out (Dil) | 54.99M | 54.06M | 53.65M | 53.23M | 52.85M | 52.48M | 53.04M | 52.12M | 50.89M | 48.95M | 45.36M | 44.29M | 44.15M | 44.04M | 42.04M | 36.20M | 26.22M | 33.83M | 31.70M | 26.29M | 25.85M | 23.62M | 16.60M | 12.96M | 12.93M | 12.58M | 12.28M | 8.38M | 8.46M | 10.33M | 8.78M | 8.78M | 8.31M | 8.30M | 8.51M | 8.27M | 8.26M | 8.25M |
Rite Aid Emerges From Bankruptcy, Names CFO Matt Schroeder as CEO
Rite Aid has announced a leadership transition as it emerges from Chapter 11 bankruptcy. Jeffrey S.
Rite Aid Picks Insider CEO As Company Emerges From Bankruptcy
Rite Aid has selected long-time company executive Matt Schroeder as the company's new chief executive officer as the company exits federal bankruptcy protection.
Rite Aid to close over two dozen stores amid bankruptcy proceedings
Rite Aid said the proceedings would involve continued store footprint optimization.
AITX CEO, Steve Reinharz, Sets Forth the Company’s Path to
Interview With SmallCapVoice.com Streaming on YouTube Now Detroit, Michigan, April 18, 2024 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions along with its wholly owned subsidiary, Robotic Assistance...
AITX’s RAD Penetrates Further into Healthcare Market with
Detroit, Michigan, April 11, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices, Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), has secured an initial order from a prominent healthcare provider ranked in the top 25 nationwide....
Unprecedented Showcasing: AITX's RAD Sets Sights on ISC West with Featured Presentations and Exposure
Detroit, Michigan, April 04, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices, Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), is pleased to announce that it will have the most feature presentations and panels in Company...
RADDOG, the Robot Dog from AITX’s RAD, Continues its Media
RADDOG is Proving to be a Media Darling in the Making Detroit, Michigan, March 25, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), today announced that RADDOG™, the...
AITX’s RAD Has Begun 100 Unit Robot Dog ‘RADDOG’ LE
With RADDOG LE Gen2, RAD Further Leans into Law Enforcement Robotics Detroit, Michigan, March 21, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), today announced that it began...
AITX’s and RAD’s ROSA Appears in ‘Cash Out’ Starring John
Action-Packed Bank Heist Film Premiered Thursday Night, with CEO Steve Reinharz in Attendance Detroit, Michigan, March 22, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), today announced that...
AITX’s RAD March 3, 2024 Investor ‘Ask Me Anything’
Discussion Items Included Company Performance, Points Related to the Stock and Other Material Items Detroit, Michigan, March 04, 2024 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX), a global leader in AI-driven security and productivity solutions along...
Source: https://incomestatements.info
Category: Stock Reports